{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:56Z","timestamp":1791356336271,"version":"4.3.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2012.12.035","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T11:46:21Z","timestamp":1356608781000},"page":"1453-1457","source":"Crossref","is-referenced-by-count":32,"title":["Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt"],"prefix":"10.1016","volume":"31","author":[{"given":"Brian","family":"Greenwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.vaccine.2012.12.035_bib0005","first-page":"3","article-title":"La m\u00e9ningite c\u00e9r\u00e9brospinale en Afrique","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2012.12.035_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.12.035_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"96","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2012.12.035_bib0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-3156.2006.01639.x","article-title":"(2006) 100 years of epidemic meningitis in West Africa \u2013 has anything changed?","volume":"11","author":"Greenwood","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.035_bib0025","first-page":"325","article-title":"Epidemic group C meningococcal meningitis in Upper Volta, 1979","volume":"61","author":"Broome","year":"1983","journal-title":"Bull World Health Org"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.035_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(02)00455-3","article-title":"Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso","volume":"2","author":"Decosas","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.12.035_bib0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningooccal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.035_bib0040","series-title":"Control of epidemic meningococcal disease: WHO practical guidelines","author":"WHO Working Group","year":"1998"},{"issue":"12","key":"10.1016\/j.vaccine.2012.12.035_bib0045","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1365-3156.2007.01929.x","article-title":"Impact of meningococcal vaccination on pharyngeal carriage of meningococci","volume":"12","author":"Dellicour","year":"2007","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.vaccine.2012.12.035_bib0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/hv.19619","article-title":"Development of a group A meningococcal conjugate vaccine: MenAfriVac (TM)","volume":"8","author":"Frasch","year":"2012","journal-title":"Hum Vaccine Immunother"},{"issue":"24","key":"10.1016\/j.vaccine.2012.12.035_bib0055","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2012.12.035_bib0060","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.12.035_bib0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.12.035_bib0070","doi-asserted-by":"crossref","unstructured":"Kristiansen PA, Diomand\u00e9 F, Ky Ba A, Sanou I, Ou\u00e9draogo A-S, Ou\u00e9draogo R, et al. Impact of serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis; published online October 19th 2012, http:\/\/dx.doi.org\/10.1093\/cid\/cis892.","DOI":"10.1093\/cid\/cis892"},{"issue":"2","key":"10.1016\/j.vaccine.2012.12.035_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/wsbm.163","article-title":"Systems vaccinology: learning to compute the behavior of vaccine induced immunity","volume":"4","author":"Nakaya","year":"2012","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.vaccine.2012.12.035_bib0080","unstructured":"World Health Organization Regional office for Africa. Meningitis Bulletin for week 26; 2012. http:\/\/www.meningvax.org\/epidemic-updates.php."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12018208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:24:13Z","timestamp":1539969853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12018208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X12018208"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}